Skip to content

Clinical trials

Myositis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myositis Country / region: United Kingdom Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20101
20111
20121
20131
20141
20161
20211
20222
20236
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting4
Terminated2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Northern Care Alliance NHS Foundation Trust2
University of Manchester2
argenx2
Abcuro, Inc.1
Amgen1
Cabaletta Bio1
EMD Serono Research & Development Institute, Inc.1
Fate Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myositis21
Dermatomyositis11
Polymyositis10
Myositis, Inclusion Body5
Arthritis, Rheumatoid2
Autoimmune Diseases2
Lung Diseases, Interstitial2
Lupus Erythematosus, Systemic2
Muscular Diseases2
Nervous System Diseases2

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.